Legend Biotech remains a buy as Carvykti's earlier-line use drives superior efficacy, safety, and manufacturing success, signaling a structural shift in multiple myeloma therapy. Recent CARTITUDE-4 ...

Initial findings show that the therapy reduced or eliminated disease signs in all recipients, sparking hopes that the treatment might be competitive with “ex vivo” medicines like Novartis’ Kymriah.

Legend Biotech (LGND) added ~26% in the morning hours on Tuesday after announcing initial results from an early-stage trial for LB2501, its in vivo CAR-T cell therapy targeting B-cell non-Hodgkin ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** If you make a short list of the ...

John Legend, the American singer-songwriter, pianist and producer, is extending his footprint in beauty with a new social impact initiative tied to his personal care brand, Loved01. Launching Monday, ...

It appears I Am Legend 2 is moving forward at Warner Bros., with reports indicating Transformers: Rise of the Beasts director Steven Caple Jr. is officially developing the sequel. I Am Legend is a ...

Italy awarded a €211 million ($249 million) grant to a company seeking to speed up processing at artificial intelligence data centers as part of a bid to support local startups. 2D Photonics Group’s ...

The singer had been repped by Ty Stiklorius, who said in a statement that she would "continue to be John’s partner in the many for-profit and non-profit ventures we built together." By Ethan Millman ...

NVIDIA's DLSS 5 has proven to be one of the more controversial announcements so far this year. When initially announced, NVIDIA CEO Jensen Huang said it was using new "neural rendering" techniques and ...